ULUSE vs ONCSM Comparison
Price, market cap, valuation, profitability and leverage metrics of ULUSE and ONCSM side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ULUSE | ONCSM | Sector median |
|---|---|---|---|
| Last price (TL) | 156.70 | 83.50 | 20.61 |
| Daily change | −6.84% | −6.29% | −4.25% |
| Market cap | TRY 12.5B | TRY 2B | TRY 3.8B |
| P/E | 16.87 | 26.70 | 16.24 |
| P/B | 13.68 | 4.21 | 1.17 |
| Dividend yield | 2.96% | — | 1.50% |
| Return on equity | 138.25% | 18.26% | −4.60% |
| Free float | 6.31% | 40.86% | 34.94% |
Popular comparisons
Related pages
About the ULUSE vs ONCSM comparison
Price, market cap, valuation multiples, profitability and leverage of ULUSE (Ulusoy Elektrik) and ONCSM (Oncosem Onkolojik Sistemler) side by side as of Sep 28, 2026, 12:18. Of the 16 metrics compared, ULUSE leads in 5 and ONCSM leads in 11.
Highlights: Daily change: ONCSM leads (−6.29% vs −6.84%). Market cap: ULUSE leads (TRY 12.5B vs TRY 2B). P/E: ULUSE leads (16.87 vs 26.70). P/B: ONCSM leads (4.21 vs 13.68). EV/EBITDA: ONCSM leads (7.50 vs 41.60). EV/Sales: ULUSE leads (2.29 vs 4.76). Gross margin: ONCSM leads (54.30% vs 12.70%). EBITDA margin (annual): ONCSM leads (41.91% vs 4.20%).
Frequently asked questions
Is ULUSE or ONCSM cheaper?
By P/E, ULUSE is cheaper (16.87 vs 26.70); by P/B, ONCSM trades at the lower multiple (13.68 vs 4.21).
Which is more profitable, ULUSE or ONCSM?
Annual net margin is 7.51% for ULUSE and 10.83% for ONCSM; return on equity is 138.25% for ULUSE and 18.26% for ONCSM.
Which is more leveraged, ULUSE or ONCSM?
The leverage ratio is 87.80 for ULUSE and 44.59 for ONCSM; net debt/EBITDA is 3.38 for ULUSE and 0.48 for ONCSM. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.